Beranda › Kanker Paru Non-Sel Kecil › Alabama › Mobile
Uji klinis Kanker Paru Non-Sel Kecil di Mobile, AL
13 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Mobile (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Menerima pesertaFase 2/3
- Southern Cancer Center, P.C., Daphne · 10 mi jauhnya
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Menerima pesertaFase 3
- Southern Cancer Center Pc, Daphne · 10 mi jauhnya
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Menerima pesertaFase 3
- Southern Cancer Center Pc, Daphne · 10 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Southern Cancer Center, Daphne · 10 mi jauhnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Southern Cancer Center, PC, Daphne · 10 mi jauhnya
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Infirmary Cancer Care, Mobile
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Menerima pesertaFase 3
- Local Institution - 0487, Mobile
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi jauhnya
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi jauhnya
- dan 1 lainnya
MYLUNG Consortium Part 3: Observational Study
Menerima pesertaStudi observasional
- Southern Cancer Center, PC, Daphne · 10 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi jauhnya
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi jauhnya
- dan 1 lainnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi jauhnya
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi jauhnya
- dan 1 lainnya
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
- University of South Alabama, Mobile
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Mobile
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Studi lain di Mobile
- Gagal Jantung13 studi
- Kanker Paru7 studi
- Kanker Payudara7 studi
- Kanker Ovarium7 studi
- Obesitas7 studi
- Kanker (semua jenis)6 studi
- Melanoma6 studi
- Kanker Paru Sel Kecil6 studi
- Penyakit Kardiovaskular6 studi
- Fibrilasi Atrium5 studi
- Kelebihan Berat Badan5 studi
- Diabetes Tipe 25 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.